ScienceDaily: Top Health News |
Breakthrough in ovarian cancer: Selumetinib Posted: 14 Feb 2013 04:41 PM PST Researchers have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib. |
You are subscribed to email updates from ScienceDaily: Top Health News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 20 West Kinzie, Chicago IL USA 60610 |
No comments:
Post a Comment